TAFFIC Tablets
Bictegravir, Emtricitabine & Tenofovir Combination
₹6500.00₹3800.00
TAFFIC Tablets combine Bictegravir 50 mg, Emtricitabine 200 mg, and Tenofovir Alafenamide 25 mg for an effective once-daily antiretroviral regimen. Specifically designed for the treatment of HIV-1 infection, this product offers potent, convenient, and reliable management. Pack contains 30 tablets. Always use under medical supervision.
TAFFIC is a fixed dose combination product (three-drug) containing Bictegravir (BIC) 50 mg, Emtricitabine (FTC) 200 mg, Tenofovir Alafenamide (TAF) 25 mg. TAFFIC is indicated for the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies per mL). The recommended dosage of TAFFIC is one tablet taken orally once daily with or without food.